REG - Tristel PLC - Director/PDMR Shareholding

TristelAnnouncement

Yesterday 10:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251212:nRSL4009La&default-theme=true

RNS Number : 4009L  Tristel PLC  12 December 2025

Tristel plc

("Tristel" or the "Company")

 

Director/PDMR Shareholding

 

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,
announces that, on 11 December 2025, Tom Jenkins, Non Executive Director of
the Company, purchased 5,400 ordinary shares of 1 penny each in the Company
("Ordinary Shares") at a price of 368 pence per Ordinary Share.

 

As a result, Tom Jenkins' beneficial interest in the Company is now 13,400
Ordinary Shares, representing 0.03 per cent. of the total issued share
capital.

 

 

For further information please contact:

 

 Tristel plc                                                                   Via Walbrook PR
 Matt Sassone, Chief Executive Officer                                         investors.tristel.com (https://investors.tristel.com/)
 Anna Wasyl, Chief Financial Officer

 Walbrook PR Ltd             Tel: 020 7933 8780 or tristel@walbrookpr.com
 Paul McManus / Lianne Applegarth / Anna Dunphy          Mob: 07980 541 893/ 07584 391 303/ 07876 741 001

 Cavendish Capital Markets Ltd                                                 Tel: 020 7220 0500
 Geoff Nash / Callum Davidson / Trisyia Jamaludin (Corporate Finance)
 Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)

 

About Tristel plc

Tristel plc is a global infection prevention company focussed on the
manufacture and supply of products using its unique proprietary chlorine
dioxide (ClO(2)) chemistry. The Company is a market leader in manual
decontamination of medical devices, supplying hospitals under the Tristel
(https://tristel.com/tristel/) brand, and under the Cache
(https://tristel.com/cache/) brand provides products for sporicidal surface
disinfection, in a format which is a sustainable alternative to commonly used
pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near
Cambridge, and operates globally employing approximately 250 people across 14
subsidiaries selling into 40 countries.

 

The Company has been listed on the London Stock Exchange's AIM market since
2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit:
https://tristel.com (https://tristel.com)

 

 

 

 Details of the person discharging managerial responsibilities / person closely
 associated
 Name                                                         Tom Jenkins
 Reason for the Notification
 Position/status                                              Director
 Initial notification/Amendment                               Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Tristel plc
 LEI                                                          2138009DZ4LH9CZGF662
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the Financial instrument, type of instrument  Ordinary shares of 1p each
 Identification code                                          GB00B07RVT99
 Nature of the transaction                                    Purchase of Ordinary Shares
 Price(s) and volume(s)                                       368 pence, 5,400 shares

 Aggregated information:                                      See above

 · Aggregated volume

 · Price
 Date of the transaction                                      11 December 2025
 Place of the transaction                                     London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFZMMZGZFGKZM



            Copyright 2019 Regulatory News Service, all rights reserved